Quality-control surveys in recent years, in various parts of the world
, have shown poor between-laboratory agreement for measurements of pla
sma proteins. Despite the existence of international reference materia
ls distributed by the World Health Organization, standards produced by
diagnostics manufacturers and professional organizations differ signi
ficantly in their ascribed values. The reasons for this are complex bu
t include poor availability of the primary materials, confusion about
their use, and the fact that their turbidity on reconstitution preclud
es their use in modern optical immunoassays. This unfortunate situatio
n led to an important initiative to produce sufficient quantities of a
widely available optically clear secondary reference material for pla
sma proteins that could be used worldwide by manufacturers, profession
al organizations, and laboratories. Here we present an overview on how
the laboratory community, including manufacturers, clinical laborator
ies, professional societies, and regulators, has reached what we consi
der is a successful conclusion to a difficult problem.